Moderna, Inc. (MRNA)

Moderna, Inc. (MRNA) is a healthcare company (biotechnology) based in the United States. The share price is $206.21, down 4.21% on the day, which values the company at $83.44B. Price as of 17 Nov 2026, 17:37 UTC, from Yahoo Finance.

Key facts

Share price
$206.21−4.21% today
Market value
$83.44B
Funk Score
28/100
Against its own history
Well above its usual priceusual price $58.08
200-week average
$82.40150% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Moderna, Inc. in more detail

MRNA trades at -49.2× next year's expected earnings, 33.0× sales. Measured against its own history, the price is 255% above what its usual multiples would imply ($58.08) — well above its usual price. It sits 150% above its 200-week average of $82.40.

Over the last five fiscal years Moderna, Inc. has compounded revenue 19.1% a year. Its Funk Score is 28 out of 100 (financial strength 6.1, profitability 0.4, growth 4.5, value 0.0, each out of 10).

In its favour: Altman Z in the safe zone; More cash than debt. Worth checking: Revenue is shrinking; Thin interest cover.

2 of the superinvestors tracked here hold MRNA, including Baillie Gifford team (2.1% of the portfolio), Ron Baron (0.4% of the portfolio).

Superinvestors holding MRNA

2 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:MRNA vs CVS (Moderna, Inc. vs CVS Health)MRNA vs SNY (Moderna, Inc. vs Sanofi)MRNA vs HCA (Moderna, Inc. vs HCA Healthcare)MRNA vs GSK (Moderna, Inc. vs GSK)MRNA vs MCK (Moderna, Inc. vs McKesson)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Moderna, Inc. (MRNA): questions and answers

What is Moderna, Inc.'s market cap?

Moderna, Inc. is valued at $83.44B at a share price of $206.21.

Is MRNA overvalued or undervalued?

Against its own history, MRNA is well above its usual price: the price is 255% above the $58.08 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is MRNA above its 200-week moving average?

Yes. MRNA is 150.3% above its 200-week average of $82.40. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Moderna, Inc. growing?

Over the last five fiscal years Moderna, Inc.'s revenue grew 19.1% a year.

Does MRNA pay a dividend?

Moderna, Inc. does not currently pay a regular dividend.

Which famous investors own MRNA?

In their latest quarterly filings, Baillie Gifford team (2.1% of the portfolio), Ron Baron (0.4% of the portfolio) hold MRNA. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Moderna, Inc. (MRNA) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/MRNA

Underlying data: Yahoo Finance; company filings with the SEC.